Background Australia introduced a national quadrivalent human papillomavirus (4vHPV)
vaccination programme for girls and young women in April, 2007. The HPV genotypes …

Identification of HPV infection as the etiologic agent of virtually all cases of cervical cancer,
as well as a proportion of other epithelial cancers, has led to development of three FDA …

We analyzed human papillomavirus (HPV) prevalences during prevaccination and
postvaccination periods to consider possible changes in nonvaccine HPV genotypes after …

Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

Abstract Background In the United States, human papillomavirus (HPV) vaccination has
been recommended for young adult men who have sex with men (MSM) since 2011 …

Background The national quadrivalent human papillomavirus (4vHPV) vaccination
programme was launched in Australia in April, 2007. In this study, we aimed to explore the …

Sub-Saharan Africa has the highest incidence of human papillomavirus (HPV) and cervical
cancer in the world, which is further aggravated by the burden of human immunodeficiency …

Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in
preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …

Objective Genital warts and human papillomavirus (HPV)-associated cancers in men can be
substantially reduced through HPV vaccination; yet, globally, HPV vaccine uptake among …